Methylenetetrahydrofolate reductase C677T polymorphism and Factor V Leiden variant in Mexican women with preeclampsia/eclampsia

Blood Cells Mol Dis. 2005 Jul-Aug;35(1):66-9. doi: 10.1016/j.bcmd.2005.03.008.

Abstract

The etiology of preeclampsia is still a matter of controversy. An association between hyperhomocysteinemia and preeclamptic patients has been described. A common missense mutation in the methylenetetrahydrofolate reductase (MTHFR) gene is associated with increased plasma homocysteine concentrations. In addition, the polymorphism of gene encoding for Factor V Leiden G1691A is associated with a prothrombotic state in heterozygous subjects. Both mutations in these thrombophilic proteins appear to have different prevalence in the general population and in patients with preeclampsia/eclampsia (PE/E). We studied single nucleotide polymorphisms for MTHFR C677T and coagulation Factor V Leiden in 33 Mexican patients with PE/E as a genetic risk factor for these diseases, comparing with a normotensive pregnant control group. The genotype and allele frequencies of MTHFR C677T and Factor V Leiden mutations between Mexican women with PE/E and healthy controls were not different. We conclude that these polymorphisms do not contribute in the etiology of PE/E as it has been reported in other populations.

MeSH terms

  • Adult
  • Case-Control Studies
  • Factor V / genetics*
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Mexico
  • Molecular Epidemiology
  • Polymorphism, Single Nucleotide*
  • Pre-Eclampsia / etiology
  • Pre-Eclampsia / genetics*
  • Pregnancy
  • Prevalence

Substances

  • factor V Leiden
  • Factor V
  • Methylenetetrahydrofolate Reductase (NADPH2)